| Jordan E Abbott, MD | |
|
2946 E Banner Gateway Dr, Gilbert, AZ 85234-2165 | |
| (480) 256-6444 | |
| (480) 256-3682 |
| Full Name | Jordan E Abbott |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Location | 2946 E Banner Gateway Dr, Gilbert, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881198588 | NPI | - | NPPES |
| Entity Name | Banner Cancer Center Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518253152 PECOS PAC ID: 6103097779 Enrollment ID: O20110913000224 |
News Archive
Nuvo Research Inc., a drug development company focused on the research and development of drug products that are delivered into and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced its financial and operational results for the quarter ended June 30, 2010.
While the blood-brain barrier (BBB) protects the brain from harmful chemicals occurring naturally in the blood, it also obstructs the transport of drugs to the brain. In an article in Nature scientists at the Swedish medical university Karolinska Institutet now present a potential solution to the problem. The key to the BBB is a cell-type in the blood vessel walls called pericytes, and the researchers hope that their findings will one day contribute to new therapies for diseases like Alzheimer's and stroke.
An anonymous donor has given $500,000 to conduct large-scale clinical trials and laboratory research on the "PapGene" test, a genomic-based screening test that detects ovarian and endometrial cancers in cervical fluid.
A Leicester cancer research project, which receives funding from Hope Against Cancer (formerly The Hope Foundation,) is investigating whether an extract from bilberries can prevent or delay the onset of certain cancers.
A drug used to treat kidney cancer also targets a genetic mutation active in about one third of patients with acute myeloid leukemia (AML), the most common and lethal form of adult leukemia, researchers at The University of Texas M. D. Anderson Cancer Center report in the Jan. 29 edition of the Journal of the National Cancer Institute.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jordan E Abbott, MD 2946 E Banner Gateway Dr, Gilbert, AZ 85234-2165 Ph: (480) 256-6444 | Jordan E Abbott, MD 2946 E Banner Gateway Dr, Gilbert, AZ 85234-2165 Ph: (480) 256-6444 |
News Archive
Nuvo Research Inc., a drug development company focused on the research and development of drug products that are delivered into and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced its financial and operational results for the quarter ended June 30, 2010.
While the blood-brain barrier (BBB) protects the brain from harmful chemicals occurring naturally in the blood, it also obstructs the transport of drugs to the brain. In an article in Nature scientists at the Swedish medical university Karolinska Institutet now present a potential solution to the problem. The key to the BBB is a cell-type in the blood vessel walls called pericytes, and the researchers hope that their findings will one day contribute to new therapies for diseases like Alzheimer's and stroke.
An anonymous donor has given $500,000 to conduct large-scale clinical trials and laboratory research on the "PapGene" test, a genomic-based screening test that detects ovarian and endometrial cancers in cervical fluid.
A Leicester cancer research project, which receives funding from Hope Against Cancer (formerly The Hope Foundation,) is investigating whether an extract from bilberries can prevent or delay the onset of certain cancers.
A drug used to treat kidney cancer also targets a genetic mutation active in about one third of patients with acute myeloid leukemia (AML), the most common and lethal form of adult leukemia, researchers at The University of Texas M. D. Anderson Cancer Center report in the Jan. 29 edition of the Journal of the National Cancer Institute.
› Verified 5 days ago
Ali M Rkein, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1688 E Boston St #101, Gilbert, AZ 85295 Phone: 480-855-0085 Fax: 480-855-0086 | |
Daniel Condie, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3530 S Val Vista Dr # B109, Gilbert, AZ 85297 Phone: 480-905-8485 Fax: 480-905-7274 | |
Robert W.h. Rampton, DO Dermatology Medicare: Medicare Enrolled Practice Location: 1688 E Boston St Ste 101, Gilbert, AZ 85295 Phone: 480-855-0085 | |
Dr. Matthew Travis Woods, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1688 E. Boston St.,, Suite 101, Gilbert, AZ 85295 Phone: 480-855-0085 Fax: 480-855-0086 | |
John Scott Kasteler, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 875 N Greenfield Rd Ste 108, Gilbert, AZ 85234 Phone: 480-801-2103 Fax: 480-801-2104 | |
Dustin James Mullens, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1459 S Higley Rd Ste 106, Gilbert, AZ 85296 Phone: 480-556-0446 Fax: 480-556-0447 |